Carl Hennigan

Now, the problem is when you look at it, there are no pharmacological treatments right now that have been shown to work that actually improve your outcomes.

And that's where there's a huge sort of number of trials going on trying to reduce the uncertainties and answer questions about what we may use, particularly to reduce your viral load, but particularly to reduce the complications.

Yeah, no, I think it's a very interesting issue.

Before we get there, let's just step back a bit and think about what's happening in the infection.

One of the problems here is we're seeing this emergence of supersized hospitals, of sucking people into hospitals and these big centres.

And we've got this 19-gale hospital happening in London, and we're going to send 4,000 people there.

But if you look at the evidence of what's happening in Italy and Spain, as you bring people into hospital, it becomes a sort of super center for the infection.

10% of all the infections in Spain are in health care workers.

Then you come into hospital.

If you haven't got the infection, you're going to definitely get it.

So it becomes a vector of carrying on the infection.

So one of the things for us is to start to consider, is it an appropriate way to deal with everybody by bringing them into hospital?

Or can you reverse that policy and start to think about, actually, can you keep people in the home setting?

And if you did that, you could give them good advice.

You could probably give them a pulse oximeter.

You could give them a thermometer.

And you could have daily contact to understand what's going on, to watch out for those who deteriorate.

Because I think there are two important issues here.

One is the deterioration into what we call viral pneumonia.

And viral pneumonia tends to be slow onset.